EE336 Budget Impact Analysis of Zanubrutinib for Patients With Treatment-Naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the United States

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.582
https://www.valueinhealthjournal.com/article/S1098-3015(22)02786-3/fulltext
Title : EE336 Budget Impact Analysis of Zanubrutinib for Patients With Treatment-Naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the United States
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02786-3&doi=10.1016/j.jval.2022.09.582
First page :
Section Title :
Open access? : No
Section Order : 10116
Categories :
Tags :
Regions :
ViH Article Tags :